Concepedia

Linda Tlili

LT

Statistics

Publications

2

Citations

90

H-Index

2

Active since

2019

Affiliations

Institut de Chimie des Substances Naturelles(Current)

Université Paris-Saclay

CNR de la Résistance aux Antibiotiques

Assistance Publique – Hôpitaux de Paris

Bicêtre Hospital

Linda Tlili is an author at Institut de Chimie des Substances Naturelles specializing in pharmacology, pharmacotherapy, and drug discovery.

Top concepts

MedicineBiochemistryPharmacologyDrug DiscoveryPharmacotherapyAntimicrobial ResistanceAntimicrobial Drug Discovery

Publications per year

2019–2021

2

Publications

2

Unravelling ceftazidime/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity

Saoussen Oueslati, Bogdan I. Iorga, Linda Tlili et al. · Journal of Antimicrobial Chemotherapy · 2019 · 69 citations · Full text

Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D)

Eugénie Romero, Saoussen Oueslati, Mohamed Benchekroun et al. · European Journal of Medicinal Chemistry · 2021 · 21 citations · Full text

Antimicrobial Drug Discovery, Class B, Non-covalent Broad-spectrum Inhibitors +11

1–2 of 2